Yasushi Tojo

451 total citations
9 papers, 372 citations indexed

About

Yasushi Tojo is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Yasushi Tojo has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 6 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Yasushi Tojo's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Yasushi Tojo is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). Yasushi Tojo collaborates with scholars based in Japan and United States. Yasushi Tojo's co-authors include Hiroaki Mitsuya, Debananda Das, Arun K. Ghosh, Yasuhiro Koh, Masayuki Amano, Toshikazu Miyakawa, Eddy Arnold, Kenji Maeda, Hirotomo Nakata and Jianping Ding and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Yasushi Tojo

8 papers receiving 367 citations

Peers

Countries citing papers authored by Yasushi Tojo

Since Specialization

Citations

This map shows the geographic impact of Yasushi Tojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Tojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Tojo more than expected).

Fields of papers citing papers by Yasushi Tojo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Tojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Tojo. The network helps show where Yasushi Tojo may publish in the future.

Co-authorship network of co-authors of Yasushi Tojo

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Tojo. A scholar is included among the top collaborators of Yasushi Tojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Tojo. Yasushi Tojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A Novel Tricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor, GRL-0739, Effectively Inhibits the Replication of Multidrug-Resistant HIV-1 Variants and Has a Desirable Central Nervous System Penetration Property In Vitro 2015 ·Antimicrobial Agents and Chemotherapy ·Masayuki Amano, Yasushi Tojo, (unknown), (unknown), Prasanth R. Nyalapatla, Debananda Das, Arun K. Ghosh, Hiroaki Mitsuya	9
2	GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants In Vitro 2013 ·Antimicrobial Agents and Chemotherapy ·Masayuki Amano, Yasushi Tojo, (unknown), (unknown), Debananda Das, Manabu Aoki, (unknown), Kalapala Venkateswara Rao, Arun K. Ghosh, Hiroaki Mitsuya	23
3	In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors 2010 ·Journal of Virology ·Yasuhiro Koh, Masayuki Amano, (unknown), (unknown), (unknown), Debananda Das, Maki Nakayama, Yasushi Tojo, Arun K. Ghosh, Hiroaki Mitsuya	76
4	Novel Protease Inhibitors (PIs) Containing Macrocyclic Components and 3( R ),3a( S ),6a( R )- bis -Tetrahydrofuranylurethane That Are Potent against Multi-PI-Resistant HIV-1 Variants In Vitro 2010 ·Antimicrobial Agents and Chemotherapy ·Yasushi Tojo, Yasuhiro Koh, Masayuki Amano, Manabu Aoki, Debananda Das, Sarang Kulkarni, David D. Anderson, Arun K. Ghosh, Hiroaki Mitsuya	19
5	Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands 2009 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, Sandra Gemma, Elena Simoni, Abigail Baldridge, D. Eric Walters, (unknown), Yasushi Tojo, Yasuhiro Koh, Masayuki Amano, Hiroaki Mitsuya	11
6	Design, Synthesis, Protein−Ligand X-ray Structure, and Biological Evaluation of a Series of Novel Macrocyclic Human Immunodeficiency Virus-1 Protease Inhibitors to Combat Drug Resistance 2009 ·Journal of Medicinal Chemistry ·Arun K. Ghosh, Sarang Kulkarni, David D. Anderson, Hong Lin, Abigail Baldridge, Yuan-Fang Wang, Alexander A. Chumanevich, Andrey Kovalevsky, Yasushi Tojo, Masayuki Amano, Yasuhiro Koh, Jordan Tang, Irene T. Weber, Hiroaki Mitsuya	35
7	Prediction of Potency of Protease Inhibitors Using Free Energy Simulations with Polarizable Quantum Mechanics-Based Ligand Charges and a Hybrid Water Model 2009 ·Journal of Chemical Information and Modeling ·Debananda Das, Yasuhiro Koh, Yasushi Tojo, Arun K. Ghosh, Hiroaki Mitsuya	69
8	Structural and Molecular Interactions of CCR5 Inhibitors with CCR5 2006 ·Journal of Biological Chemistry ·Kenji Maeda, Debananda Das, (unknown), Hirotomo Nakata, Toshikazu Miyakawa, Yasushi Tojo, (unknown), Yoshikazu Takaoka, Jianping Ding, Gail Ferstandig Arnold, Eddy Arnold, Hiroaki Mitsuya	130
9	Tasking deadlocks in programs with the full Ada 95 2005 ·ACM SIGAda Ada Letters ·Yasushi Tojo, (unknown), Yuichi Goto, Jingde Cheng	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact